Molecular Diagnostic Pricing Database

All

All prices for Abbott, Cepheid and Roche are indicative; small variations are possible based on the individual components in any given order.

Abbott

Abbott mPima pricing: The exact price point within the range provided will depend on the combination of existing instruments (which were purchased) and new instruments (which will be placed), as well as whether the existing instruments are under warranty.

Instrument placement assumes utilizing in-country molecular infrastructure and placing additional equipment only if volumes justify doing so.

Other countries can be added based on instrument launch

Other countries or regions can be added on an ad-hoc basis

Abbott is in the process of revising the volume tiers and establishing global base prices with committed volumes for HIV, HBV and HCV tests. Please confirm updates with supplier.

Cepheid

Applicable only to 10-color systems

MTB/RIF (GX4) is being discontinued

This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by the authorized laboratories; this product has been authorized only for the detection of nucleic acid from monkeypox virus or other non-variola orthopoxviruses, not for any other viruses or pathogens; and the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

6-color devices (R1 model) have been discontinued, though countries can continue to receive technical support and replacement parts. A trade in program to switch R1 devices for R2 devices is available, details linked.

 A flyer with information about all-inclusive pricing is available here.

Cepheid’s pricing for all GX assays indicated above is prepaid (payment made in full before goods are shipped) and when procured directly from Cepheid. Additional cost would be added when incoterm is different from EXW and/or when goods are procured through a local distributor.

Other incoterms are possible at additional cost, please contact Cepheid directly

Applicable only to GX XVI platforms

S&M would be included for all GX XVI platforms placed in the price per test

Cepheid’s pricing for all GX assays indicated above is prepaid (payment made in full before goods are shipped) and when procured directly from Cepheid. Additional cost would be added when incoterm is different from EXW and/or when goods are procured through a local distributor.

Each GX XVI placement requires an annual purchase of 10,000 tests (of any corresponding assay listed except SARS-CoV-2) spread across all GeneXpert systems in the participating country.

Specific incoterm to be decided based on negotiation

Hologic

Instrument placement assumes utilizing in-country molecular infrastructure and placing additional equipment only if volumes justify doing so

Subject to minimum annual aggregate volume of 30,000 tests per Panther System instrument per year with an install base of ≥2 Panther System instruments across eligible assays and sample types. If the minimum volume commitment cannot be met,special pricing that is volume based and tiered for HIV (VL and EID) may apply for eligible countries. Please contact Hologic directly.

This is a ceiling price associated with the minimum annual aggregate volume commitmentof 30,000 tests per Panther System instrument per year with an install based of >2 Panther System instruments across eligible assays and sample types; lower prices may be accessed on a country-by-country basis.

Special all-inclusive pricing for HPV is enabled through an annual test volume commitment under the Global Health Supply Chain – Procurement and Supply Management Project (GHSC-PSM) and is subject to change.

Special global pricing for HIV (VL and EID) is enabled through an annual test volume commitment under the Global Health Supply Chain – Procurement and Supply Management Project (GHSC-PSM) and is subject to change.

Roche

Different prices may apply for special projects/grants, please contact Roche directly

MTB/ RIF-INH – The Roche Global Access Program pricing model encourages reflex RIF/INH testing as per WHO Guidance. price per test for every patient is $8.90 ($7.90 + $1.00 for RIF/INH reflex)

Different prices may apply for special projects/grants, please contact Roche directly

Instrument Surcharge (Reagent Rental) is determined by the total annual volumes of all tests (HIV, HPV, MTB and HCV/HBV, COVID-19) at the country level averaged across the entire footprint; for country specific details please contact Roche directly

Service Surcharge is determined by the total annual volumes of all tests (HIV, HPV, MTB and HCV/HBV, COVID-19) at the country level averaged across the entire footprint, for country specific details please contact Roche directly

Supply Chain Surcharge for Incoterms DAP is determined by country specific factors considering volatility around logistics costs, for country specific details please contact Roche directly

MolBio

20 Truenat MTB/RIF tests free with purchase of 100 Truenat MTB/MTBPLUS tests purchased. In the future users will be able to select a combination of MTB/RIF and INH

UNO workstation = UNODx + TrueprepAUTO + Printer + Pipette + Accessories

DUO workstation = DUODx + TrueprepAUTO + Printer + Pipette + Accessories

QUATTRO workstation = QUATTRO + 2 units TrueprepAUTO + Printer + Pipette + Accessories